DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo

4.64 -0.02 (-0.43%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ARNA $4.64 -0.43%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.61
Previous Close $4.66
Daily Range $4.55 - $4.73
52-Week Range $3.26 - $7.22
Market Cap $1.1B
P/E Ratio -16.64
Dividend (Yield) $0.00 (0.0%)
Volume 3,121,066
Average Daily Volume 4,007,832
Current FY EPS -$0.56




Drug Makers

Arena Pharmaceuticals, Inc. (ARNA) Description

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Website:

News & Commentary

3 Promising Healthcare Stocks Under $10

Healthcare stocks with plenty of potential -- and low share prices

Don't Write Off Arena As Yet

Arena, Eisai Finish Phase I Studies on Obesity Drug Belviq - Analyst Blog

Arena, Eisai Finish Phase I Studies on Obesity Drug Belviq - Analyst Blog

Jefferies: 10 Buyout Targets To Own During The M&A Boom

Vivus Sales Remain Flat - Stock Trend Not Good

Arena's 15,000 Scripts Set Pace Vs. Competitors

The Best Stock to Invest in Obesity Drugs

Making money helping people shed the pounds.

Seeking Alpha's Biotech Weekly: A Biogen Deep Dive, Eisai's Arena Shuffle, And More

Arena's Partner Eisai Is Slashing Jobs - What Investors Need To Consider

Health Care Sector Update for 04/10/2015: ARNA, VRTX, ANIP

See More ARNA News...

ARNA's Top Competitors

ARNA $4.64 (-0.43%)
Current stock: ARNA
AMGN $163.58 (-1.97%)
Current stock: AMGN
GILD $101.38 (-1.90%)
Current stock: GILD
BIIB $419.44 (-2.15%)
Current stock: BIIB